Easywell Biomedicals, Inc. (1799.TWO)

70.10 -0.20 (-0.28%) At close: 01:30PM CST

Easywell Biomedicals, Inc.

No.10, Yanfa 2nd Road
Hsinchu Science Park
Hsinchu City 30076
Taiwan
886 3 666 9596
https://www.easywellbio.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. James Lee Ph.D.	President	N/A	N/A	N/A
Dr. Yu-Hsing Tu Ph.D.	Chief Science Officer	N/A	N/A	N/A
Dr. She Bin-Ru Ph.D.	Chief Technical Officer of Regenerative Medicine Division	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Easywell Biomedicals, Inc. develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in the United States and Asia. It develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; and TLX-011 for treatment of inflammatory lesions of rosacea. The company also develops TWB-201 for Parkinson patch; TLX-501, an urinary medicine; and TLX-502, a pneumonia medicine. In addition, it provides medical devices. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.

Corporate governance

Easywell Biomedicals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.